Functional investigation of troponin with the homozygous HCM mutation, TNNT2 K280N, obtained from an explanted heart

Functional investigation of troponin with the homozygous HCM mutation, TNNT2 K280N, obtained from an explanted heart

Détails bibliographiques
Auteurs principaux:	Bayliss, C, Messer, A, Leung, M, Ward, D, Van Der Velden, J, Poggesi, C, Redwood, C, Marston, S
Format:	Conference item
Publié:	2012

Documents similaires

The HCM-associated cardiac Troponin T mutation K280N causes reduced responsiveness to protein kinase A
par: Van Der Velden, J, et autres
Publié: (2012)

The HCM-Associated Cardiac Troponin T Mutation K280N Increases the Energetic Cost of Tension Generation in Human Cardiac Myofibrils
par: Ferrara, C, et autres
Publié: (2013)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
par: Redwood, C, et autres
Publié: (2001)

Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
par: Vasco Sequeira, et autres
Publié: (2022-09-01)

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation
par: Messer, A, et autres
Publié: (2016)

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
par: Preston, L, et autres
Publié: (2006)

In vitro motility studies of HCM and DCM mutations in cardiac muscle actin
par: Dyer, E, et autres
Publié: (2007)

Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
par: Bayliss, C, et autres
Publié: (2013)

A Novel Homozygous Intronic Variant in TNNT2 Associates With Feline Cardiomyopathy
par: James W. McNamara, et autres
Publié: (2020-11-01)

Evidence for haploinsufficiency as the mechanism of action of MyBP-C mutations that cause HCM
par: Carballo, S, et autres
Publié: (2008)

HCM and DCM mutations in thin filament proteins have opposite effects on in vitro motility
par: Marston, S, et autres
Publié: (2002)

Cardiac Troponin T (TNNT2) plays a potential oncogenic role in colorectal carcinogenesis
par: Yifan Liu, et autres
Publié: (2023-07-01)

HCM and DCM mutations in thin filament proteins have opposite effects on regulation of contractility in vitro
par: Redwood, C, et autres
Publié: (2003)

Correction: Cardiac Troponin T (TNNT2) plays a potential oncogenic role in colorectal carcinogenesis
par: Yifan Liu, et autres
Publié: (2023-12-01)

HCM and DCM mutations in cardiac thin filament proteins have opposite effects on the regulation of contractility in vitro
par: Redwood, C, et autres
Publié: (2003)

Mouse HCM Model Expression E99K ACTC Mutation Reproduces the Clinical HCM Phenotype
par: Song, W, et autres
Publié: (2009)

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
par: Josè Manuel Pioner, et autres
Publié: (2022-04-01)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
par: Abdulrazzak, H, et autres
Publié: (2001)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
par: Robinson, P, et autres
Publié: (2003)

Pressure Overload Is Associated With Low Levels of Troponin I and Myosin Binding Protein C Phosphorylation in the Hearts of Patients With Aortic Stenosis
par: O’neal Copeland, et autres
Publié: (2020-03-01)

Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants
par: Rahana Y. Parbhudayal, et autres
Publié: (2020-04-01)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
par: Robinson, P, et autres
Publié: (2002)

Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silico
par: Yang, Z, et autres
Publié: (2024)

Interaction analyses elucidate the pathophysiology of HCM-causing missense mutations in cardiac myosin binding protein-C.
par: Moolman-Smook, J, et autres
Publié: (2001)

Structure-function relationships of eight mutations in troponin and tropomyosin that cause dilated cardiomyopathy
par: Mirza, M, et autres
Publié: (2004)

DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation.
par: Preston, L, et autres
Publié: (2007)

Mutations in fast skeletal troponin I, troponin T and beta-tropomyosin that cause distal arthrogryposis all enhance thin filament activation
par: Robinson, P, et autres
Publié: (2005)

Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
par: Burton, D, et autres
Publié: (2002)

A comparative study of mutation screening of sarcomeric genes (MYBPC3, MYH7, TNNT2) using single gene approach versus targeted gene panel next generation sequencing in a cohort of HCM patients in Egypt
par: Heba Sh. Kassem, et autres
Publié: (2017-10-01)

Dilated cardiomyopathy causing mutations in cardiac troponin T (TNT), cardiac troponin C (TNC), and alpha tropomyosin (TM) reduce CA(2+) sensitivity and maximum calcium activation
par: Redwood, C, et autres
Publié: (2004)

Using fluorescence emission spectroscopy to asses the Ca2+ affinity of reconstituted troponin and thin filaments containing cardiomyopathy causing mutations of troponin and alpha-tropomyosin
par: Robinson, P, et autres
Publié: (2007)

Slower calcium handling balances faster cross-bridge cycling in human MYBPC3 HCM
par: Pioner, JM, et autres
Publié: (2023)

Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function.
par: Robinson, P, et autres
Publié: (2007)

Investigating the role of uncoupling of Troponin I phosphorylation from changes in myofibrillar Ca2+-sensitivity in the pathogenesis of Cardiomyopathy
par: Andrew Easton Messer, et autres
Publié: (2014-08-01)

Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silico
par: Zeyu Yang, et autres
Publié: (2024-12-01)

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy
par: Elliott, K, et autres
Publié: (2000)

Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
par: Robinson, P, et autres
Publié: (2002)

A novel interaction between the C5 and C8 domains of myosin binding protein-C and its modulation by HCM mutations
par: Flashman, E, et autres
Publié: (2002)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
par: Burton, D, et autres
Publié: (2002)

Cardiac Overexpression of XIN Prevents Dilated Cardiomyopathy Caused by TNNT2 ΔK210 Mutation
par: Bin Li, et autres
Publié: (2021-06-01)